Page 4 - Latest Updates on Diabetes
Diabetes myths vs facts: 15 health risks you may be unknowingly taking
Fact-Check Friday: From the belief that fruits are bad to blaming sugar alone, doctors bust 15 widespread diabetes myths and offer clear, science-backed facts for better care
 "Diabetes myths vs facts: 15 health risks you may be unknowingly taking")
Why jamun seed powder is called a superfood for managing diabetes
Jamun seed powder contains jamboline and jambosine that help regulate blood sugar, support pancreatic function, and may aid in diabetes prevention if used correctly
 "Why jamun seed powder is called a superfood for managing diabetes")
Understanding gestational diabetes: Why early detection, awareness matter
Despite common misconceptions, gestational diabetes can affect healthy women of any age or body type. Often symptomless, it frequently goes undiagnosed-putting both mother and child at risk
 "Understanding gestational diabetes: Why early detection, awareness matter")
Does your job involve meeting people? It may raise diabetes risk: Study
A 14-year study of nearly 3 million people found that emotional strain in public-facing roles may increase type 2 diabetes risk by up to 47 per cent
 "Does your job involve meeting people? It may raise diabetes risk: Study")
Stem cell breakthrough: New therapy raises hopes of curing type 1 diabetes
A new stem cell-based treatment helped most trial participants with severe type 1 diabetes stop insulin use, offering hope for long-term freedom from injections
 "Stem cell breakthrough: New therapy raises hopes of curing type 1 diabetes")
Abbott, MSD join hands to distribute key diabetic drug across India
Abbott to distribute MSD's sitagliptin portfolio-Januvia, Janumet, Janumet XR-in India, targeting deeper reach in the ₹950-1,000 crore diabetes drug segment
 "Abbott, MSD join hands to distribute key diabetic drug across India")
That 'healthy' juice habit? It might be messing with your metabolism
Think juice is better than soda? A large new study shows even 100% fruit juice raises diabetes risk, urging people to eat whole fruits instead
 "That 'healthy' juice habit? It might be messing with your metabolism")
Obesity injections may have less weight loss effect in reality: Study
The study, published in the Obesity Journal, examined the effects of anti-obesity injectables on weight reduction and blood sugar regulation (glycaemic control) in a real-world setting
 "Obesity injections may have less weight loss effect in reality: Study")
Eli Lilly's weight loss drug Mounjaro sales bulk up 60% on dosage upgrade
It logged value sales worth Rs 12.61 crore in May, compared to Rs 7.88 crore in April.
 "Eli Lilly's weight loss drug Mounjaro sales bulk up 60% on dosage upgrade")
Lilly's obesity drug Mounjaro's sales rise 60% in India amid rising demand
The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm Pharmarack Technologies
Biocon gets CDSCO approval for generic diabetes medication 'Liraglutide'
The approval is for the generic version of Victoza, indicated for the treatment of insufficiently controlled Type 2 Diabetes Mellitus in adults, adolescents and children aged 10 years and above
 "Biocon gets CDSCO approval for generic diabetes medication 'Liraglutide'")
Novo Nordisk to launch weight-loss drug Wegovy in India ahead of schedule
Amid rising demand and Eli Lilly's Mounjaro launch, Novo Nordisk is advancing plans to introduce its obesity drug Wegovy in the Indian market
 "Novo Nordisk to launch weight-loss drug Wegovy in India ahead of schedule")
Can the '2 per 20' rule really help stabilise blood sugar without exercise?
Research shows that light walking for 2 minutes after every 20 minutes of sitting may significantly lower post-meal blood sugar levels
 "Can the '2 per 20' rule really help stabilise blood sugar without exercise?")
5 products to be launched in 18 mths, US insulin mkt share up: BBL MD & CEO
Achieving 15 per cent year-on-year growth, with nearly four biosimilars with $200 million in revenue, is a big feat, says Tambe
 "5 products to be launched in 18 mths, US insulin mkt share up: BBL MD & CEO")
Insulin's century-old legacy still stands tall amid new diabetes drugs
Despite the rise of GLP-1s and oral therapies, insulin remains vital for millions, particularly those with type 1 diabetes and other insulin-dependent conditions
 "Insulin's century-old legacy still stands tall amid new diabetes drugs")
Patent loss led to rise in prescriptions of new generation diabetes drugs
Experts say 85% price drop in empagliflozin expected to boost SGLT2 usage; SGLT-2 class of drugs account for 25-30% of all diabetes prescriptions
 "Patent loss led to rise in prescriptions of new generation diabetes drugs")
What is Type 5 diabetes? IDF recognises malnutrition-linked condition
Long overlooked and often misdiagnosed, Type 5 diabetes, caused by malnutrition-linked reduced insulin production, has finally gained official recognition
 "What is Type 5 diabetes? IDF recognises malnutrition-linked condition")
Hit the gym! Building muscles may cut diabetes risk by 44%, genes no bar
Muscle up, sugar down: A new study has found individuals with high muscle strength have a 44% lower risk of developing type 2 diabetes, irrespective of their genetic predisposition to the disease
 "Hit the gym! Building muscles may cut diabetes risk by 44%, genes no bar")
Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India. Prices here
Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what you need to know
Glenmark launches Empagliflozin for diabetes in India under Glempa brand
The medications are designed to improve glycemic control in adults with type 2 diabetes mellitus while also reducing cardiovascular outcomes in patients with cardiovascular risk
 "Glenmark launches Empagliflozin for diabetes in India under Glempa brand")